Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Feb 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how well "intranasal fentanyl," a pain relief medication given through the nose, is being used in children who come to the emergency department with musculoskeletal pain, like injuries to bones or muscles. The researchers at Strasbourg University Hospital want to look back at how this medication has been prescribed and monitored in kids treated from August 2022 to September 2024. The goal is to ensure that the treatment is both effective and safe for young patients.

To participate in this study, children must be under 18 years old and have received intranasal fentanyl at the pediatric emergency department of Strasbourg University Hospital during the study period. Their parents or guardians should also agree to allow the use of their child's health data for research purposes. If eligible, families can expect that their child's treatment information will be reviewed to help improve pain management practices in the future. Please note, children whose families decline to participate or whose medical records are incomplete won't be included in the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Child \< 18 years old
• • Child treated in the pediatric emergency department of Strasbourg University Hospital
• • Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024.
• • Child (and/or his/her parental authority) who has not expressed, after information, his/her (their) opposition to the reuse of his/her health data for the purposes of this research.
• Exclusion Criteria:
• • Refusal of the child (and/or his/her parent) to participate in the study
• • Patient's medical file not incomplete
• • Child not domiciled in France.